Qcm Cayman, Ltd. Amgen Inc Transaction History

Qcm Cayman, Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $261,409 - $304,630	-1,178 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $75,083 - $89,411	347 Added 41.76%	1,178 $271,000
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $194,994 - $216,849	831 New	831 $211,000
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $265,496 - $310,266	-1,567 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $264,493 - $295,520	1,567 New	1,567 $273,000
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $199,075 - $227,290	-1,190 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,190	1,190 $205,000

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Qcm Cayman, Ltd., based on Form 13F filings with the SEC.

Stay updated on Qcm Cayman, Ltd. with notifications on news.